Suppr超能文献

尿白细胞介素-18作为预测经皮冠状动脉介入治疗患者造影剂肾病的早期指标。

Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

作者信息

He Haiyan, Li Wenhua, Qian Wenhao, Zhao Xin, Wang Lin, Yu Yaren, Liu Jiali, Cheng Jing

机构信息

Department of Cardiology, Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, P.R. China.

出版信息

Exp Ther Med. 2014 Oct;8(4):1263-1266. doi: 10.3892/etm.2014.1898. Epub 2014 Aug 11.

Abstract

Contrast-induced nephropathy (CIN) is at present the third leading cause of hospital-acquired acute kidney injury (AKI). Traditionally, it is diagnosed by measuring an increase of the serum creatinine (SCr) concentration. However, SCr is an insensitive marker for detecting CIN. This study was designed to investigate whether human urinary interleukin-18 (IL-18) is early predictive marker for CIN following coronary interventional procedures. The general clinical data of 180 patients who underwent coronary interventional procedures at the Department of Cardiology, Affiliated Hospital of Xuzhou Medical College from March 1, 2012 to September 31, 2012 were collected. A nonionic, low osmolality contrast agent was used in the laboratory at this time. SCr values and estimated glomerular filtration rate (eGFR) were measured prior to and within 24 and 48 h after the administration of contrast agents. Urine samples were collected prior to and 2, 6, 12, 24 and 48 h after the coronary interventional procedure, and urinary IL-18 levels were measured using an ELISA kit. CIN was defined as an increase of ≥0.5 mg/dl or ≥25% in SCr concentration over baseline 24-48 h after the procedure. CIN occurred in 16 of 180 (8.9%) patients. The levels of urinary IL-18 measured 2 h after the procedure were increased in the CIN group, but the increase was not significant (P>0.05). There were significant differences (P<0.05) between the urinary IL-18 levels 6, 12, 24 and 48 h after the procedure and those before the procedure. No significant difference was identified between the SCr levels measured prior to and 24 h after the procedure. The area under the receiver operating characteristic (ROC) curve of urinary IL-18 12 h after the procedure was 0.811 and the 95% confidence interval of the area under the curve was 0.735-0.888. If the critical point of the diagnosis of CIN was 815.61 pg/ml, the sensitivity was 87.5% and the specificity was 62.2%. Univariate analysis indicated that the urinary IL-18 level was positively correlated with the SCr concentration pre- and postprocedure. In conclusion, urinary IL-18 may be a promising indicator for the early prediction of CIN.

摘要

对比剂肾病(CIN)目前是医院获得性急性肾损伤(AKI)的第三大主要原因。传统上,它是通过测量血清肌酐(SCr)浓度的升高来诊断的。然而,SCr是检测CIN的不敏感标志物。本研究旨在调查人尿白细胞介素-18(IL-18)是否为冠状动脉介入术后CIN的早期预测标志物。收集了2012年3月1日至2012年9月31日在徐州医学院附属医院心内科接受冠状动脉介入手术的180例患者的一般临床资料。此时在实验室使用了非离子型、低渗性对比剂。在给予对比剂之前以及之后24小时和48小时内测量SCr值和估计肾小球滤过率(eGFR)。在冠状动脉介入手术之前以及之后2、6、12、24和48小时收集尿液样本,并使用酶联免疫吸附测定试剂盒测量尿IL-18水平。CIN定义为术后24 - 48小时SCr浓度较基线升高≥0.5 mg/dl或≥25%。180例患者中有16例(8.9%)发生了CIN。CIN组术后2小时测量的尿IL-18水平升高,但升高不显著(P>0.05)。术后6、12、24和48小时的尿IL-18水平与术前水平之间存在显著差异(P<0.05)。术后24小时测量的SCr水平与术前相比无显著差异。术后12小时尿IL-18的受试者工作特征(ROC)曲线下面积为0.811,曲线下面积的95%置信区间为0.735 - 0.888。如果CIN诊断的临界点为815.61 pg/ml,敏感性为87.5%,特异性为62.2%。单因素分析表明,术前和术后尿IL-18水平与SCr浓度呈正相关。总之,尿IL-18可能是早期预测CIN的一个有前景的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c6e/4151647/4e1e8259f4b1/ETM-08-04-1263-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验